It was the most symbolic moment of Saturday night/Sunday morning. When a beefy, scruffy Oscar De La Hoya entered the ring at the MGM Grand, walked over to Amir Khan after his decisive clinic against a ...

CLEVELAND, Ohio — Want to beat the Cavs? It’s not exactly a state secret anymore. The latest Wine and Gold Talk podcast laid bare a harsh truth that’s becoming increasingly obvious around the NBA: ...

Blueprint Medicines Corporation BPMC reported a fourth-quarter 2023 loss of $1.82 per share, narrower than the Zacks Consensus Estimate of a loss of $2.04 and a loss of $2.65 in the year-ago quarter.

Blueprint Medicines (BPMC) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook ...